0000899243-19-003848.txt : 20190215
0000899243-19-003848.hdr.sgml : 20190215
20190215163138
ACCESSION NUMBER: 0000899243-19-003848
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190213
FILED AS OF DATE: 20190215
DATE AS OF CHANGE: 20190215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gover Justin D.
CENTRAL INDEX KEY: 0001754129
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35892
FILM NUMBER: 19611928
MAIL ADDRESS:
STREET 1: SOVEREIGN HOUSE, VISION PARK, HISTON
CITY: CAMBRIDGE
STATE: X0
ZIP: CB24 9BZ
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GW PHARMACEUTICALS PLC
CENTRAL INDEX KEY: 0001351288
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: SOVEREIGN HOUSE
STREET 2: VISION PARK
CITY: HISTON, CAMBRIDGE CB24 9BZ
STATE: X0
ZIP: 00000
BUSINESS PHONE: 44 1223 266800
MAIL ADDRESS:
STREET 1: SOVEREIGN HOUSE
STREET 2: VISION PARK
CITY: HISTON, CAMBRIDGE CB24 9BZ
STATE: X0
ZIP: 00000
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-13
0
0001351288
GW PHARMACEUTICALS PLC
GWPH
0001754129
Gover Justin D.
SOVEREIGN HOUSE, VISION PARK, HISTON
CAMBRIDGE
X0
CB24 9BZ
UNITED KINGDOM
1
1
0
0
Chief Executive Officer
Ordinary Shares
2019-02-13
4
S
0
22620
12.50
D
370445
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 16, 2018.
These ordinary shares are represented by American Depositary Shares of the Issuer ("ADS"). Each ADS represents twelve ordinary shares of the Issuer. The reporting person acquired these shares on December 20, 2018 in connection with an exercise of options that were due to expire on December 24, 2018.
The price reported in Column 4 is price per ordinary share ($150.0 per ADS).
/s/ Justin D. Gover
2019-02-15